American Electric Power Company Inc
Change company Symbol lookup
Select an option...
AEP American Electric Power Company Inc
BAF BlackRock Municipal Income Investment Quality Trust
HRTH Harte Hanks Inc
STRA Strategic Education Inc
TFECY Thin Film Electronics ASA
ELY Callaway Golf Co
WBA Walgreens Boots Alliance Inc
GOOG Alphabet Inc
CUB Cubic Corp
BAC Bank of America Corp
Go

Utilities : Electric Utilities | Large Cap Value
Company profile

American Electric Power Company, Inc. (AEP) is a public utility holding company that owns, directly or indirectly, all of the outstanding common stock of its public utility subsidiaries and varying percentages of other subsidiaries. The service areas of the Company's public utility subsidiaries cover the states of Arkansas, Indiana, Kentucky, Louisiana, Michigan, Ohio, Oklahoma, Tennessee, Texas, Virginia and West Virginia. The Company's segments include Vertically Integrated Utilities, Transmission and Distribution Utilities, AEP Transmission Holdco, and Generation & Marketing. AEP's vertically integrated utility operations are engaged in the generation, transmission and distribution of electricity for sale to retail and wholesale customers. Transmission and Distribution Utilities segment consists of the transmission and distribution of electricity for sale to retail and wholesale customers. AEP Transmission Holdco develops, constructs and operates transmission facilities.

Closing Price
$85.37
Day's Change
0.55 (0.65%)
Bid
--
Ask
--
B/A Size
--
Day's High
85.54
Day's Low
84.28
Volume
(Light)
Volume:
2,276,418

10-day average volume:
3,226,737
2,276,418

Dexcom G6 Continuous Glucose Monitoring System Now Available at Veterans Affairs Pharmacies Across the United States

8:30 am ET September 22, 2020 (BusinessWire) Print

DexCom, Inc. (NASDAQ:DXCM) announced today the Dexcom G6 Continuous Glucose Monitoring (CGM) System is now available at Veterans Affairs (VA) pharmacies, improving access to CGM and empowering veterans with diabetes to better manage their condition. Veterans with Type 1 or Type 2 diabetes who meet the qualifying coverage criteria have 100% of the costs of Dexcom G6 covered by the VA.

"Previously, VA prescriptions for Dexcom CGM were filled through the Durable Medical Equipment channel, which can result in additional costs and potential delays for patients in obtaining the system and its supplies. In the past, patients may have waited two to six weeks for supplies, but now VA patients who are prescribed Dexcom G6 will be able to start CGM and refill supplies in just two to three days at their local VA pharmacy," said Kevin Sayer, chairman, president and CEO of Dexcom. "Veterans have made incredible sacrifices on behalf of our country, and they deserve to have access to the most innovative technology that can help make diabetes management easier and improve their health."

Veterans are 2.5 times more likely to have diabetes than the general population--with one in four veterans diagnosed with diabetes. The VA's new streamlined prescription and pharmacy process for Dexcom G6 CGM will make it easier for veterans to obtain and adhere to CGM, helping to improve diabetes management for this important population.

"Easier access to CGM at the pharmacy is a big win for veterans with diabetes. Research continues to show CGM should be the standard of care for any diabetes patient on intensive insulin therapy," said Dhiren Patel, PharmD, CDCES, BC-ADM, BCACP, an endocrine clinical pharmacy specialist. "Dexcom G6 has a number of highly beneficial features including predictive low alerts to help avoid dangerous low blood sugar events, time-in-range reports, and remote monitoring capabilities that allow patients to share their glucose data in real time with up to 10 followers."

Dexcom G6 features and benefits:

Fingerstick elimination - No fingersticks needed for calibration or diabetes treatment decisions* Continuous glucose readings - Automatically sends glucose readings to a Dexcom receiver or compatible smart device+ every five minutes Mobile app and sharing - Compatibility with smart device+ apps allows for sharing glucose information with up to 10 people for added support+ Customizable alarms and alerts - Personalized alert schedule immediately warns the wearer of pending dangerous high and low blood sugars Easy sensor applicator - One-touch, simple insertion Discreet and low profile - Transmitter with a 28% lower profile than previous generation Dexcom CGMs makes the device comfortable and easy to wear under clothing Acetaminophen blocking - Allows for more accurate glucose readings with no medication interference Predictive low alert - Predicts hypoglycemia before it hits to help avoid dangerous low blood sugar events Extended 10-day sensor - Allows for 43% longer wear than previous generation Dexcom CGMs

The new government contract and procurement pathway at the VA for Dexcom G6 makes prescribing Dexcom CGM now more cost effective and efficient for the VA.

Dexcom G6 is 100% covered for VA patients who meet the following coverage criteria:

Has diabetes mellitus Requires an intensive insulin regimen (e.g. greater-than or equal to3 injections a day, or insulin pump) to achieve desired glycemic control (target range) based upon shared-decision making) Requires frequent blood glucose monitoring (greater-than or equal to4 or more times a day) Has the knowledge and skill set necessary to successfully utilize CGM Agrees to ongoing medical appointments with multidisciplinary team at least every six months to assess the adherence and benefit derived from CGM Meets at least one of the following criteria: At risk for hypoglycemia Unable to meet glycemic control despite adherence to the treatment regimen Performing job-related activities where a hypoglycemic event could put them at risk of harm Unable to perform self-monitoring of blood glucose due to disability or disease

Patients and VA healthcare providers can learn more about starting or prescribing Dexcom CGM through the VA at Dexcom.com/veterans.

About DexCom, Inc.

Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. For more information about Dexcom CGM, visit www.dexcom.com.

*If your glucose alerts and readings from the Dexcom G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

+ For a list of compatible devices, visit www.dexcom.com/compatibility.

+Separate Follow App required.

The urgent low soon can warn you in advance of severe hypoglycemia--allowing you time to take appropriate action before it happens.

Dexcom, Dexcom G6, and Dexcom CLARITY are registered trademarks of Dexcom, Inc. in the United States and/or other countries. (C)2019 Dexcom Inc. All rights reserved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200922005240/en/

SOURCE: DexCom, Inc.

Media Contact: 
James McIntosh, (619) 884-2118
Dexcom Public Relations
james.mcintosh@dexcom.com

Investor Contact: 
Steve Pacelli, (858) 200-0200
Dexcom Strategy and Corporate Development
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.